Camp4 Therapeutics (CAMP) Current Leases (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Current Leases of $384000.0 for Q1 2026, up 34.27% sequentially from $286000.0 in Q4 2025, and down 87.49% YoY from $3.1 million in Q1 2025.
Analysis
Camp4 Therapeutics (CAMP) Current Leases (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Current Leases for 4 years, with the latest figure at $384000.0 in Q1 2026.
- Quarterly Current Leases fell 87.49% year-over-year to $384000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $384000.0 (down 87.49% YoY) and the FY2025 annual result came in at $286000.0, down 90.45% from the prior year.
- Current Leases improved to $384000.0 in Q1 2026 per CAMP's latest filing, from $286000.0 in the prior quarter.
- Over five years, Current Leases peaked at $3.1 million in Q2 2025 and troughed at $27000.0 in Q3 2025.
- A 4-year average of $1.6 million and a median of $1.7 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2025: Current Leases jumped 745.76% in 2024, then plunged 99.08% in 2025.
- Over 4 years, Current Leases stood at $354000.0 in 2023, then surged by 745.76% to $3.0 million in 2024, then sank by 90.45% to $286000.0 in 2025, then jumped by 34.27% to $384000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $384000.0, $286000.0, and $27000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Camp4 Therapeutics | 260.10 Mn | 260.10 Mn | - | 802,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 802,000.00 |
| Mar 31, 2026 | 384,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Dec 31, 2023 | 2.70 Mn |